Practice Management News

Adolescents can overcome circadian phase delay and boost their sleep duration with an earlier bedtime, according to a study published in Pediatrics.

Jesse M. Ehrenfeld, MD, MPH, FAMIA, FASA, was recently sworn in as president of the AMA.

There is “wide variation” in the way clinicians measure and report the physician’s global assessment of disease activity in patients with juvenile idiopathic arthritis, according to data published in Rheumatology.

During its House of Delegates meeting, the AMA voted to oppose noncompete agreements for physicians employed by hospitals or staffing company employers.

Only one-quarter of residential addiction treatment centers caring for adolescents in the United States offer buprenorphine to patients with opioid use disorder, according to findings published Tuesday in JAMA.

Huma Therapeutics announced that it has received class II clearance from the FDA for its disease management platform, which facilitates data collection from patients for self-management or remote assessment by health care providers.

Many investors have recently been asking their advisors, “Is a recession coming?” This question is often on the minds of investors because the financial media repeatedly brings up the topic.

The FDA recently approved two separate vaccines to prevent respiratory syncytial virus in older adults. Soon, additional RSV prevention tools may be available for pediatric patients, too.

HHS has released a list of 43 prescription drugs for which Part B beneficiary coinsurances may be lower starting July 1.

An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.